Ranked #1 in 8 out of the 10 evaluated specialties by U.S. News
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Fibrous dysplasia is a developmental abnormality that results in abnormal growth, pain and deformity of the affected bones.
The condition is subdivided into three types:
Treatment with medication?
There are early studies that suggest that drugs that alter bone resorption may help the pain of fibrous dysplasia and may strengthen the bone. At this time, this therapy is not of proven value, but it does hold promise for the future. Researchers at Boston Children's Hospital are continuously investigating new forms of treatment.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”